Ke-xin Wen

Ke-xin Wen is a Researcher in the Department of Clinical Genetics at Erasmus MC, a leading medical center affiliated with Erasmus University Rotterdam. Their work spans multiple disciplines including immunology, genetics, and neurology, with a particular focus on migraine research and autoimmune diseases.

Dr. Wen's research interests primarily focus on the intersection of immunology and neurology. Their work examines how genetic factors influence neurological conditions, particularly migraines, and how immune responses contribute to vascular and neurological disorders. They have made significant contributions to understanding the role of dendritic cells and Th17 cells in autoimmune conditions, as well as investigating genetic variants that affect cerebral blood flow and vascular health in migraine patients. The research fingerprint shows strong engagement with Berylliosis (100%), Tertiary Lymphoid Structure (100%), Th17 Cell (100%), and Dendritic Cell (100%) research areas.

The publication portfolio demonstrates a consistent interdisciplinary approach connecting genetics, immunology, and neurology. Recent work has expanded into large-scale genetic studies and metabolomics approaches to understand migraine pathophysiology. Dr. Wen's articles reveal a progression from cellular and animal model research toward population-level studies examining vascular components of neurological disorders.

Dr. Wen has been actively involved in major collaborative research initiatives, including the Rotterdam Study, a prospective cohort study ongoing since 1990 in Rotterdam, Netherlands. Their work often involves large-scale data analysis and international research collaborations across multiple institutions, as evidenced by their contribution to the Nature Communications paper analyzing data from over 300,000 individuals.